Jakavi 15 mg

JAKAVI 15 MG tablets contain ruxolitinib, a medication used to manage certain conditions related to the immune system. This oral treatment is designed to help regulate immune responses and may be prescribed for specific therapeutic uses.

JAKAVI 15 MG tablets are primarily used to manage conditions involving overactive immune responses. Ruxolitinib, the active ingredient, works by inhibiting specific enzymes to help control inflammation and immune system activity. This medication may be prescribed for conditions where immune regulation is necessary, such as certain blood disorders or inflammatory diseases.

Common effects of JAKAVI 15 MG tablets may include fatigue, dizziness, and mild gastrointestinal discomfort. Some individuals might experience changes in blood cell counts, which is why regular monitoring is often recommended. Always consult a healthcare provider for personalized advice.

JAKAVI 15 MG tablets should be handled with care, especially if you have a history of infections or blood disorders. It is important to follow the prescribed dosage and inform your healthcare provider about any other medications you are taking. Regular blood tests may be necessary to monitor your response to the treatment.

JAKAVI 15 MG tablets may interact with certain medications, including those that affect liver enzymes or other immune system modulators. Alcohol and other substances that suppress the immune system should be used with caution. Always discuss potential interactions with your healthcare provider.